Cargando…
aFGF alleviates diabetic endothelial dysfunction by decreasing oxidative stress via Wnt/β-catenin-mediated upregulation of HXK2
Vascular complications of diabetes are a serious challenge in clinical practice, and effective treatments are an unmet clinical need. Acidic fibroblast growth factor (aFGF) has potent anti-oxidative properties and therefore has become a research focus for the treatment of diabetic vascular complicat...
Autores principales: | Sun, Jia, Huang, Xiaozhong, Niu, Chao, Wang, Xuejiao, Li, Wanqian, Liu, Mengxue, Wang, Ying, Huang, Shuai, Chen, Xixi, Li, Xiaokun, Wang, Yang, Jin, Litai, Xiao, Jian, Cong, Weitao |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7772795/ https://www.ncbi.nlm.nih.gov/pubmed/33360774 http://dx.doi.org/10.1016/j.redox.2020.101811 |
Ejemplares similares
-
Fibroblast growth factor 7 alleviates myocardial infarction by improving oxidative stress via PI3Kα/AKT-mediated regulation of Nrf2 and HXK2
por: Mei, Lin, et al.
Publicado: (2022) -
FGF13 Is a Novel Regulator of NF-κB and Potentiates Pathological Cardiac Hypertrophy
por: Sun, Jia, et al.
Publicado: (2020) -
FGF13 Is a Novel Regulator of NF-κB and Potentiates Pathological Cardiac Hypertrophy
por: Sun, Jia, et al.
Publicado: (2023) -
Repression of myogenic differentiation by aFGF, bFGF, and K-FGF is dependent on cellular heparan sulfate
Publicado: (1992) -
Hypoglycemic Efficacy of Rh-aFGF Variants in Treatment of Diabetes in ZDF Rats
por: Zhang, Li, et al.
Publicado: (2021)